CVE:CRMCRH Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CRH Medical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.67 million shsAverage Volume5.83 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlinesOptions ChainSocial Media CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for CRH Medical. Previous Next 2.5 Community Rank Outperform VotesCRH Medical has received 125 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCRH Medical has received 126 “underperform” votes. (Add your “underperform” vote.)Community SentimentCRH Medical has received 50.20% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote “Outperform” if you believe CRM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCRH Medical does not currently pay a dividend.Dividend GrowthCRH Medical does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CRH Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$23,540.00 in company stock and sold C$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.10 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolCVE:CRM Previous Symbol CUSIPN/A CIKN/A Webinvestors.crhsystem.com Phone+1-604-6331440Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable TSXV:CRM Rates by TradingView Receive CRM News and Ratings via Email Sign-up to receive the latest news and ratings for CRM and its competitors with MarketBeat's FREE daily newsletter. CRH Medical (CVE:CRM) Frequently Asked Questions Has CRH Medical been receiving favorable news coverage? Media headlines about CRM stock have trended positive on Saturday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a media sentiment score of 2.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutCRH Medical. What other stocks do shareholders of CRH Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include Co-Diagnostics (CODX), Ibio (IBIO), Pharmacyte Biotech (PMCB), RingCentral (RNG), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY). Who are CRH Medical's key executives? CRH Medical's management team includes the following people: Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)Edward J. Wright, Chief Executive Officer, DirectorRichard K. Bear, Chief Financial Officer (Age 48)Jay Kreger, President of CRH Anesthesia ManagementDavid Johnson, Independent DirectorBergein F. Overholt M.D., Independent DirectorTodd R. Patrick, Independent Director (Age 48)Ian A. Webb, Independent Director (Age 61) What is CRH Medical's stock symbol? CRH Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CRM." How do I buy shares of CRH Medical? Shares of CRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is CRH Medical's official website? The official website for CRH Medical is investors.crhsystem.com. How can I contact CRH Medical? CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440. This page was last updated on 6/6/2020 by MarketBeat.com Staff
